このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

スマート減量管理 (SMART)

2026年10月27日 更新者:Northwestern University

The overall objective of this study is to use an innovative experimental approach, the SMART (Sequential Multiple Assignment Randomized Trial), to determine the best way to sequence the delivery of mHealth tools and traditional treatment components in a stepped program of obesity treatments. The SMART approach is a highly efficient strategy for identifying and constructing efficacious adaptive interventions: it accommodates sequential decision-making based on the participant's response to early weight loss treatment components. The proposed treatment package begins with the least expensive components, and for participants identified as treatment non-responders, provides sequential step-up of additional treatment components. By sequentially delivering treatment components based on participant response, SMART permits achievement of the target outcome, weight loss, with least resource consumption and participant burden.

調査の概要

詳細な説明

The proposed study seeks to develop an effective, resource-sensitive strategy to manage weight loss treatment for obesity. During the 12-week active intervention phase, participants will be randomized to one of two first-line treatments: 1) mobile app alone (APP) or 2) app plus bi-weekly telephone coaching sessions (APP+C). Beginning at week 2, those who are identified as treatment non-responders (did not lose an average of 0.5 lbs/week) will be re-randomized to one of two augmentation tactics: 1) Modest Step-up, operationalized as the addition of an additional mHealth component, or 2) Vigorous Step-up, operationalized as the addition of an additional mHealth component plus a traditional weight loss intervention component. Treatment responders will continue with the same first-line treatment. Treatment response be re-assessed at weeks 4 and 8. Those identified as treatment non-responders will be re-randomized at that time.

研究の種類

介入

入学 (実際)

400

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Illinois
      • Chicago、Illinois、アメリカ、60611
        • Northwestern University

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~60年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • 18 through 60 years old
  • BMI between 27 - 45 kg/m2
  • < 350 lbs
  • Weight stable (no loss or gain >25 lbs. for the past 6 months)
  • Interested in losing weight and not enrolled in a formal weight loss program or taking medications or supplements that may cause weight change
  • Own a Smartphone and be willing to install the SMART App
  • Reside in the Chicago area for the duration of their participation (12 months)

Exclusion Criteria:

  • Unstable medical conditions (uncontrolled hypertension, diabetes - uncontrolled or treated with insulin, uncontrolled hypothyroidism, unstable angina pectoris, transient ischemic attack, cancer undergoing active treatment, cerebrovascular accident or myocardial infarction within the past six months, or Crohn's disease)
  • Pregnancy, lactation, or intended pregnancy
  • Active suicidal ideation, anorexia, bulimia, binge eating disorder, current substance abuse or dependence (besides nicotine dependence)
  • Require assistive device for mobility or current condition that may limit or prevent participation in moderate activity
  • Use of pacemaker or other electrical implanted device
  • History of bariatric (or LapBand) surgery, or considering or currently on a wait-list for bariatric or LapBand surgery
  • May not live with a current or past SMART study participant

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:階乗代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:APP

This arm included participants who responded to the App condition and did not require step-up at the end of stage 1.

In stage 1, participants received a study-specific smartphone app to track weight, dietary intake and physical activity, and a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker. Participants used their own smartphone to receive the study smartphone application.

In stage 2, responders to App continued to receive the smartphone app and technology core.

Participants will receive a smartphone app to track weight, dietary intake and physical activity, and a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker. Participants will use their own smartphone to receive the study smartphone application.

実験的:APP, Modest Step-Up

This arm included participants who did not respond to the App condition in stage 1.

In stage 1, participants received a study-specific smartphone app to track weight, dietary intake and physical activity, and a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker. Participants used their own smartphone to receive the study smartphone application.

In stage 2, non-responders to APP received a modest step up of an additional mHealth intervention component (push notifications). Participants continued to receive their first line treatment.

In addition to the first line treatment, participants identified as non-responders will be provided an additional mHealth intervention component (push notifications) plus a traditional weight loss intervention component (coaching), for the remainder of their 12-week intervention.

実験的:APP, Vigorous Step-Up

This arm included participants who did not respond to the App condition in stage 1.

In stage 1, participants received a study-specific smartphone app to track weight, dietary intake and physical activity, and a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker. Participants used their own smartphone to receive the study smartphone application.

In stage 2, non-responders to APP received a vigorous step up of an additional mHealth intervention component (push notifications), plus a traditional weight loss intervention component (meal replacements). Participants continued to receive their first line treatment.

In addition to first line treatment, participants identified as non-responders will be provided an additional mHealth intervention component (push notifications) for the remainder of their 12 week intervention.

実験的:APP + Coaching

This arm included participants who responded to the App+Coaching condition and did not require step-up at the end of stage 1.

In stage 1, participants received a study-specific smartphone app to track weight, dietary intake and physical activity; a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker; and 12 weekly telephone coaching sessions. Participants used their own smartphone to receive the study smartphone application.

In stage 2, responders to App+Coaching continued to receive the smartphone app, technology core, and coaching sessions.

In addition to first line treatment, participants identified as non-responders will be provided an additional mHealth intervention component (push notifications) for the remainder of their 12 week intervention.

実験的:APP + Coaching, Modest Step-Up

This arm included participants who did not respond to the App+Coaching condition in stage 1.

In stage 1, participants received a study-specific smartphone app to track weight, dietary intake and physical activity; a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker; and 12 weekly telephone coaching sessions. Participants used their own smartphone to receive the study smartphone application.

In stage 2, non-responders to APP+Coaching received a modest step up of an additional mHealth intervention component (push notifications). Participants continued to receive their first line treatment.

Participants will receive a smartphone app to track weight, dietary intake and physical activity; a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker; 12 weekly telephone coaching sessions. Participants will use their own smartphone to receive the study smartphone application.

実験的:APP + Coaching, Vigorous Step-Up

This arm included participants who did not respond to the App+Coaching condition in stage 1.

In stage 1, participants received a study-specific smartphone app to track weight, dietary intake and physical activity; a technology core consisting of web-based weekly lessons, wireless scale, and activity tracker; and 12 weekly telephone coaching sessions. Participants used their own smartphone to receive the study smartphone application.

In stage 2, non-responders to APP+Coaching received a vigorous step up of an additional mHealth intervention component (push notifications), plus a traditional weight loss intervention components (meal replacements). Participants continued to receive their first line treatment.

In addition to the first line treatment, participants identified as non-responders will be provided an additional mHealth intervention component (push notifications) plus a traditional weight loss intervention component (meal replacements), for the remainder of their 12-week intervention.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Weight at 6 Months
時間枠:baseline, 6 months

Weight measured in the lab, taken without shoes, wearing light clothing on a calibrated beam balance scale

baseline, 6 months

その他の成果指標

結果測定
メジャーの説明
時間枠
Change in Weight at 12 Months
時間枠:baseline, 12 months

Weight measured in the lab, taken without shoes, wearing light clothing on a calibrated beam balance scale

baseline, 12 months
Cost Effectiveness
時間枠:12 months

Cost/pound lost of each study sequence embedded within the SMART design.

12 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Bonnie Spring, PhD、Northwestern University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2017年6月19日

一次修了 (実際)

2020年9月17日

研究の完了 (実際)

2021年3月18日

試験登録日

最初に提出

2016年12月5日

QC基準を満たした最初の提出物

2016年12月16日

最初の投稿 (推定)

2016年12月20日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年10月27日

最終確認日

2026年10月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • NIH NIDDK R01DK108678
  • R01DK108678 (米国 NIH グラント/契約)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する